Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT05999799 ·Status: TERMINATED ·Phase: PHASE2

A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

NCT06881251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

NCT03389893 ·Status: TERMINATED ·Phase: PHASE4

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

NCT05923099 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis

NCT03492398 ·Status: COMPLETED ·Phase: PHASE1

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

NCT07193589 ·Status: RECRUITING ·Phase: PHASE2

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

NCT06564389 ·Status: RECRUITING ·Phase: PHASE1

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

NCT07230860 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT03985943 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT03989349 ·Status: COMPLETED ·Phase: PHASE3

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

NCT04992546 ·Status: COMPLETED ·Phase: PHASE2

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

NCT06988605 ·Status: RECRUITING

A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

NCT05486208 ·Status: TERMINATED ·Phase: PHASE1

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

NCT02465606 ·Status: COMPLETED ·Phase: PHASE2

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Lebrikizumab in Moderate-to-severe Atopic Dermatitis

NCT06906497 ·Status: RECRUITING ·Phase: PHASE4

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

NCT06487000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

NCT05117060 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

NCT03054428 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT05911841 ·Status: TERMINATED ·Phase: PHASE2

A Study in Subjects With Moderate Atopic Dermatitis

NCT03175354 ·Status: COMPLETED ·Phase: PHASE2